112 active trials 58 recruiting 6 Phase 3 30 disease areas 2 changes in 30 days
2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.
Primary endpoint(s) modified
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolEarly Phase 1 NCT07748156 Registry history of NCT07748156 on ClinicalTrials.gov (opens the registry)
Updated
Registry marked status Unknown (sponsor has not verified the record since Apr 2022); last known: Recruiting
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolNot specified NCT05357456 Registry history of NCT05357456 on ClinicalTrials.gov (opens the registry)
Changed
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-01 | NCT07852806 Bone Marrow Mononuclear Cells for the Repair of Severe Maxillofacial Bone Defects | Recruiting | |
| 2026-09-22 | NCT07833345 AI-Assisted Euploid Embryo Selection for Single-Blastocyst Transfer in Women of Advanced… | Not Yet Recruiting | |
| 2026-09-21 | NCT07831993 Sintilimab Plus NALIRIFOX or Gemcitabine-Cisplatin as First-Line Treatment for Metastatic… | Phase 2 | Recruiting |
| 2026-09-17 | NCT07824440 a Salivary Cell-free RNA Liquid Biopsy Model for Non-invasive Diagnosis in Sjögren's… | Completed |
| Early Phase 1 | 5 | |
| Phase 1 | 5 | |
| Phase 1/2 | 6 | |
| Phase 2 | 25 | |
| Phase 3 | 6 | |
| Phase 4 | 5 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT07163650 | Evaluating Anti-Obesity Medications 6 Months After Metabolic Surgery | Obesity | Recruiting | 2026-01-27 |
| NCT07677566 | 177Lu-PSMA-617 Combined With Darolutamide in Neoadjuvant Treatment of High-risk Localized… | Prostate Cancer | Not Yet Recruiting | 2026-07-01 |
| NCT07274644 | Effects of iGlarLixi Versus iGlar on Liver Fat Content in Patients With Type 2 Diabetes… | Metabolic Dysfunction-Associated Steatotic Liver Disease | Active, Not Recruiting | 2026-06-22 |
| NCT07372612 | Flow-diverting Devices for the Treatment of Middle Cerebral Artery Bifurcation Aneurysms | Aneurysms | Not Yet Recruiting | 2026-01-28 |
| NCT06486363 | Comparison of the Antiplatelet Efficacy of Aspirin Combined With Clopidogrel and Aspirin… | Intracranial Aneurysms | Not Yet Recruiting | 2024-07-29 |
| Phase 3 | ||||
| NCT07083154 | Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study) | Dementia, Mild | Recruiting | 2026-09-02 |
| NCT06968806 | Study on Ketorolac for Improving Outcomes and Prognosis in Patients With Stanford Type A… | Aortic Dissection | Recruiting | 2026-08-31 |
| NCT06118034 | Effect of Colchicine on Perioperative Anti-inflammatory Organ Injury in Cardiac Surgery | Inflammatory Response | Recruiting | 2025-11-17 |
| NCT06361238 | Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac Surgery | Delirium, Postoperative | Recruiting | 2024-12-20 |
| NCT04595864 | Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma… | Hepatocellular Carcinoma | Recruiting | 2021-11-05 |
| NCT06966765 | Accelerated vs Standard Approach to Continuous Veno-venous Hemodiafiltration… | Diquat Poisoning | Not Yet Recruiting | 2025-11-18 |
| Phase 2 | ||||
| NCT07831993 | Sintilimab Plus NALIRIFOX or Gemcitabine-Cisplatin as First-Line Treatment for Metastatic… | Biliary Tract Cancer | Recruiting | 2026-09-21 |
| NCT07797816 | Liposomal Irinotecan Plus 5-FU/LV and Sintilimab With Sequential SBRT for Locally… | Biliary Tract Cancer | Recruiting | 2026-09-01 |
| NCT07711314 | Adjuvant Rezvilutamide Monotherapy for High-Risk Prostate Cancer After Radical… | Prostate Cancer (Post Prostatectomy) | Recruiting | 2026-07-23 |
| NCT07514637 | Safety and Efficacy of Anricfen for Postoperative Analgesia and Rehabilitation Promotion… | Patients Who Undergo Pancreaticoduodenectomy | Recruiting | 2026-04-07 |
| NCT06662006 | Nal-IRI/5-FU/LV Chemotherapy Combined With PD-L1 Inhibitor and Multi-target… | Advanced Metastatic Pancreatic Cancer | Recruiting | 2026-02-06 |
| NCT05758389 | Tislelizumab Combined APF Chemotherapy in the Treatment of Locally Advanced Head and Neck… | Head and Neck Tumors | Recruiting | 2025-09-05 |
| NCT07093866 | Efficacy and Safety of Disitamab Vedotin Plus Abiraterone for Metastatic… | mCRPC | Recruiting | 2025-07-30 |
| NCT06992232 | Radiotherapy or Surgery Combined With Intense Androgen Deprivation Therapy for mCRPC | Prostate Cancer Metastatic Disease | Recruiting | 2025-05-28 |
| NCT06791148 | Low-dose Radiotherapy Combined With Chemotherapy and AK112 as Second-line Treatment in… | Gastric Cancer | Recruiting | 2025-01-24 |
| NCT06389760 | Nimotuzumab Combined With mFOLFIRINOX/GX as Postoperative Adjuvant Therapy in Pancreatic… | Pancreatic Cancer | Recruiting | 2024-10-31 |
| NCT06305832 | Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without… | Prostate Cancer | Recruiting | 2024-03-12 |
| NCT06151262 | A Study of Trilaciclib Combined With mFOLFIRINOX in the Treatment of Patients With… | Pancreatic Cancer | Recruiting | 2024-02-23 |
| NCT05687357 | Tislelizumab in Combination With Pre-operative CRT Versus SOC for Locally Advanced G/GEJ… | Gastric Cancer | Recruiting | 2023-04-19 |
| NCT05768464 | Postoperative Adjuvant Therapy for Non-clear Renal Cell Carcinoma With High-risk… | Non-clear Renal Cell Carcinoma | Recruiting | 2023-03-14 |
Diabetes (10) · Prostate Cancer (10) · Type 2 Diabetes (7) · Obesity (6) · Pancreatic Cancer (6) · NASH / MASH (4) · Gastric Cancer (3) · Lupus (SLE) (3) · Type 1 Diabetes (3) · Bladder Cancer (2)